{"id":"W4388627499","doi":"10.25251/skin.7.supp.241","title":"Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials","year":2023,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Psoriasis; Placebo; Clinical endpoint; Apremilast; Clinical trial; Internal medicine; Randomized controlled trial; Tolerability; Adverse effect; Gastroenterology; Dermatology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004397077,0.0007635757,0.001721508,0.000250291,0.0005837412,0.001211489,0.0005601296,0.001112353,0.001509184],"category_scores_gemma":[0.001862702,0.0002816262,0.001810562,0.00035539,0.0004099661,0.001039582,0.0003340814,0.002671143,0.0003689524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007368333,"about_ca_system_score_gemma":0.0009790433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000603025,"about_ca_topic_score_gemma":0.002115932,"domain_scores_codex":[0.9987385,0.000683032,0.00008916436,0.000165841,0.0001570711,0.0001664917],"domain_scores_gemma":[0.9987153,0.0002901009,0.0003937305,0.0001154571,0.0001299085,0.0003555485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6706421,0.01492109,0.01360807,0.002309233,0.004432453,0.0003804491,0.000456894,0.002396657,0.02561028,0.0004568557,0.008238106,0.2565478],"study_design_scores_gemma":[0.5507982,0.3368468,0.0831691,0.0003698612,0.003205492,0.001468985,0.0001659207,0.002693504,0.007170412,0.0009837011,0.01301707,0.0001109195],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9727342,0.01943066,0.0006033939,0.0007696229,0.0001484802,0.001344202,0.0008969262,0.0001219579,0.00395061],"genre_scores_gemma":[0.9914819,0.003787139,0.0007161771,0.0006400284,0.0001637798,0.001076077,0.001216157,0.00002047725,0.0008982925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004397077,"threshold_uncertainty_score":0.02325428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03370635970462376,"score_gpt":0.3210922749445532,"score_spread":0.2873859152399295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}